What Is Type 3 Diabetes? Insulin Resistance In The Brain That Could Trigger Alzheimer’s
Most people are aware of type 1 and type 2 diabetes, but did you know there is a type 3 diabetes as well! It is a more obscure term. Although it is not an accepted medical diagnosis, type 3 diabetes has been discussed in the literature as a possible relationship between insulin resistance in the brain and Alzheimer's disease. This link has been described to help explain how metabolic disorders impact brain health, causing cognitive decline and dementia.
Type 3 diabetes is more of a misnomer because it should not be confused with type 3c diabetes, which relates to pancreatic dysfunction. The term "type 3 diabetes," on the other hand, has been loosely used by some scientists to analogously propose that Alzheimer's disease is strongly implicated with insulin resistance in the brain.
This concept was conceptualized by Dr. Suzanne de la Monte and Dr. Jack Wands of Brown University in the year 2008. This hypothesis postulated that Alzheimer's disease may be called type 3 diabetes for it bears many similarities with glucose metabolism disorder type 2 diabetes. Their concept arises from the basic principle that insulin is fundamental to blood sugar regulation, but it is also the case with the brain. When brain cells become insulin-resistant, they lose access to glucose, impairing their function.
Research published in the Journal of Diabetes Science and Technology supports this hypothesis by indicating that insulin resistance can be a significant contributor to the occurrence of dementia, also referred to as Alzheimer's. The symptoms of memory loss and diminished reasoning are associated with impaired glucose metabolism in the body, especially in the cerebral tissue.
Although type 3 diabetes is not a "medical term," its symptoms correlate well with Alzheimer's diseases that are known to reduce the ability to think in an efficient manner and bring down brain health. These signs are:
- Loss of memory, especially short-term.
- Poor judgment and judgment ability
- Failure in recognizing people or places familiar once.
- Failure in the process of reading, writing or processing numbers
- Anxiety, agitation, or mood changes.
- Disorganized thoughts or confusion
- Lack of impulse control
As the disease advances, patients may be afflicted with severe complications including an inability to swallow or control their bodily functions. In the final stages, most patients die from fatal complications such as aspiration pneumonia.
This may not be well understood with regards to type 3 diabetes, or the exact link between insulin resistance and Alzheimer's disease. Some identified contributing factors include the following:
Insulin acts as an important regulatory mechanism of brain functions such as memory and cognition. The reduction in insulin signaling may impair metabolism of brain cells, thus bringing about neurodegeneration.
These diseases show a strong relationship and those individuals diagnosed with type 2 diabetes have double chances of getting Alzheimer's. In the two, the main causes can be chronic inflammation, oxidative stress, and a defect in glucose metabolism.
Insulin resistance associated with obesity, stress, and an unhealthy diet is considered a cause that may increase the chances of Alzheimer's disease.
Researches in Frontiers in Neuroscience and The Lancet Neurology have also highlighted that drugs used for antidiabetic medication may be crucial for the prevention or at least slowing down the course of Alzheimer's.
In 2022, in a study in Pharmaceuticals, researchers studied biomarker uptake in brain regions implicated in the faulty uptake and metabolism of blood sugar in Alzheimer’s patients.
Emerging Therapies
Research into such treatments as intranasal insulin has also been promising. Intranasal delivery of insulin directly to the brain has been reported to enhance glucose uptake by brain cells, improve memory, and boost cognitive performance. While such clinical trials have been shown to be successful, additional research is needed for safety and efficacy.
Medications
For patients being aggressive or agitated, antipsychotic drugs may be prescribed; however, therapies such as cognitive rehabilitation as well as cognitive stimulation therapy serve to preserve memory and executive function.
Lifestyle Interventions
Diet, exercise, and stress management are critical in preventing and managing insulin resistance. A review in the Journal of Alzheimer's Disease also highlighted the benefits of Kirtan Kriya meditation, which can regulate genes involved in insulin and glucose metabolism, improve sleep, and reduce inflammation.
Although type 3 diabetes is not officially recognized, its connection to Alzheimer’s disease underscores the importance of proactive measures for brain health. Some prevention strategies include:
1. Healthy Diet
Consuming a balanced diet rich in antioxidants, whole grains, and healthy fats may support brain health.
2. Regular Exercise
Physical activity improves insulin sensitivity, reduces inflammation, and enhances overall metabolic health.
3. Stress Reduction
Mindfulness practices, including meditation, have been shown to lower stress levels, which can reduce the risk of cognitive decline.
The term type 3 diabetes brings out the complex relationship between metabolic disorders and brain health. Even though it is not a recognized medical condition, the concept emphasizes the crucial role of insulin in brain function and its possible contribution to Alzheimer's disease. Continued research will hopefully provide hope for therapies such as intranasal insulin and lifestyle modifications.
Credit: AI
America's falling birth rate is often reported with concerns like shortage of labour, a growing aging population, and slower population growth. But another major consequence is unfolding within the healthcare system that is going unnoticed.
As fewer women have children and more delay pregnancy, women's healthcare is evolving beyond maternity care to address changing health needs.
According to the latest data from the U.S. Centers for Disease Control and Prevention (CDC), 3.63 million babies were born in the United States in 2024, a slight increase from 2023.
However, the general fertility rate fell to a record-low 53.8 births per 1,000 women aged 15 to 44, marking the lowest level ever recorded.
One of the biggest changes is maternity care. With fewer births being reported, hospitals, particularly in rural communities, are struggling to keep labour and delivery departments financially viable.
The problem has contributed to the rise of a maternity care challenge where pregnant women have limited or no access to obstetric services.
The 2024 March of Dimes Maternity Care Deserts Report found that more than one in three U.S. counties lack a single obstetric clinician or birthing facility, leaving millions of women with reduced access to prenatal and delivery care.
Women living in these areas are more likely to receive inadequate prenatal care and experience higher rates of preterm birth.
Also read: Beyond The Bump: Why Preconceptions And Antenatal Care Are Key To A Healthy Pregnancy
At the same time, healthcare providers are broadening their focus beyond pregnancy. Women today are delaying childbirth, having fewer children, or choosing not to become parents altogether.
As life expectancy increases, demand is growing for services related to menopause, cardiovascular disease, osteoporosis, pelvic floor disorders, mental health, and healthy aging.
The shift also explains why fertility care is expanding despite declining birth rates. As more Americans postpone parenthood into their late 30s and 40s, many require fertility evaluations, egg freezing, or in vitro fertilization (IVF).
Rather than indicating more births, the growing use of assisted reproductive technology reflects changing reproductive timelines.
An aging female population is also changing healthcare priorities. Older women face a higher risk of chronic diseases such as heart disease, diabetes, osteoporosis, and dementia, increasing the need for preventive care and long-term disease management.
Health systems are investing more in menopause clinics, wellness programs, and other women's health services.
America's falling birth rate is therefore reshaping far more than population statistics. It is redefining women's healthcare, shifting the focus from pregnancy-related care to comprehensive support throughout every stage of life.
On World Population Day, the conversation is not just about how many babies are being born. It is also about ensuring that healthcare evolves to meet the changing needs of women, whether or not they choose to become mothers.
Credit: iStock
Chai and pakoras are practically non-negotiable once the rains set in. For a large number of Indians, though, monsoon comes with something less welcome: a blocked nose, itchy eyes, and a "cold" that just won't quit.
Most people write this off as a seasonal cold. It's often not. A large share of the patients I see in July aren't fighting a fresh infection. They're dealing with allergic rhinitis that's been present for months at a manageable level, and monsoon has simply pushed it past a threshold they can no longer ignore.
The scale of this is easy to underestimate. A national study under the Global Asthma Network, which surveyed more than 1.27 lakh children, adolescents, and adults across India, found that close to a quarter of Indian adolescents aged 13 to 14 live with allergic rhinitis. Roughly one in ten adults does too.
Other Indian research puts the overall incidence of allergic rhinitis anywhere between 20 and 30 percent of the population. This isn't a niche complaint. It's one of the more common chronic conditions walking through general practice doors, most of which are simply unnamed.
The same national study found something more concerning: nearly three out of four people who met the clinical criteria for allergic rhinitis had never actually been diagnosed with it. Many had lived with recurring congestion, sneezing, and disturbed sleep for years without anyone connecting the dots.
A separate survey of over 1,600 physicians across India found that while a large share see allergic rhinitis routinely in practice, more than half had never used immunotherapy, one of the few treatments that changes the course of the disease rather than just quieting it temporarily.
Indian allergen-testing data show a clear rotation of triggers through the year: dust mites dominate winter, pollens dominate summer, and fungal and insect allergens rise sharply once the rains set in.
The reason is straightforward. Once relative humidity in a city climbs past 70 percent, which happens routinely through the monsoon, fungal spores and dust mites both multiply fast. Waterlogging pushes fungal spore counts up further. A damp curtain or a mattress that never quite dries between showers becomes a long-term allergen source that outlasts any single rainy day.
Allergic skin and eye conditions tend to flare with the same seasonal humidity and allergen load as allergic rhinitis, and in practice, they rarely show up in isolation. A patient with monsoon-triggered nasal symptoms is worth a closer look for coexisting asthma, eczema, or conjunctivitis, simply because in the Indian patient population, these conditions travel together more often than not.
For anyone with a known allergic condition, a few habits make a real difference once the rains arrive:
Monsoon doesn't create new allergy patients. It reveals how well the existing ones are actually being looked after.
“Let knowledge be your shield against the changing seasons."
Credit: iStock
Even a mild case of COVID-19 may trigger long-lasting eye problems, with new research revealing that persistent inflammation and nerve damage could be responsible for symptoms that standard eye tests often fail to detect.
The study, led by researchers at Linköping University in Sweden and published in Nature Communications, sheds light on why some COVID-19 survivors continue to experience debilitating vision issues months or even years after infection.
The research began after people who had recovered from mild COVID-19 sought medical help for persistent eye complaints. Many reported:
Many participants said the condition significantly disrupted their daily lives, preventing them from working or continuing their education.
Also read: Experts Say US Cyclospora Parasite Outbreak Is Unusual: How To Clean Fresh Produce
Researchers evaluated 100 people who developed eye problems after mild COVID-19 but had never been hospitalized. Their symptoms had persisted anywhere from three months to three years.
The findings were compared with those of 32 people who had recovered from mild COVID-19 without developing eye symptoms.
Using advanced imaging and laboratory techniques, researchers identified several abnormalities that conventional eye exams failed to detect.
The study found evidence of:
Lead author Petros Moustardas, senior research associate at Linköping University, said the findings indicate that COVID-19 may trigger a severe immune reaction in the eyes, resulting in chronic inflammation and nerve dysfunction.
Read More: Obesity-Driven CKM Syndrome A Growing Public Health Threat, Warns American Heart Association
One of the most common complaints among participants was extreme sensitivity to light. Researchers found that their pupils were allowing too much light into the eyes because of impaired nerve control.
This abnormal pupil function was also associated with:
The study also identified impaired coordination between the two eyes.
Some participants developed adult-onset strabismus—commonly known as crossed eyes—a condition that is rare in adults.
Researchers believe this occurred because COVID-19 affected the nerves responsible for controlling eye muscles.
Because routine eye tests often miss these abnormalities, the research team developed two diagnostic models.
The first relies on specialized ophthalmic tests available at advanced eye clinics, while the second combines these examinations with tear fluid protein analysis to improve diagnostic accuracy.
Researchers hope these models will help doctors recognize COVID-related eye syndrome earlier and pave the way for future treatments.
"We found that the problems experienced by those affected were not detectable by standard tests. We had to perform specialised examinations to detect deviations. The puzzle pieces then fell into place, and we found explanations for the symptoms," said Neil Lagali, professor of experimental ophthalmology at Linköping University.
He added that while the findings provide important clues about how COVID-19 affects the eyes, more research is needed to develop effective treatments for those living with persistent vision problems.
© 2024 Bennett, Coleman & Company Limited